Publication: Zebularine regulates early stages of mESC differentiation: effect on cardiac commitment.
dc.contributor.author | Horrillo, A | |
dc.contributor.author | Pezzolla, D | |
dc.contributor.author | Fraga, M F | |
dc.contributor.author | Aguilera, Y | |
dc.contributor.author | Salguero-Aranda, C | |
dc.contributor.author | Tejedo, J R | |
dc.contributor.author | Martin, F | |
dc.contributor.author | Bedoya, F J | |
dc.contributor.author | Soria, B | |
dc.contributor.author | Hmadcha, A | |
dc.contributor.authoraffiliation | [Horrillo,A; Pezzolla,P; Aguilera,Y; Soria,B; Hmadcha,A] Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER)– Fundación Progreso y Salud, Sevilla, Spain. [Pezzolla,P; Salguero-Aranda,C; Tejedo,JR; Martin,F; BedoyaFJ; Soria,B; Hmadcha,A] CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain. [Fraga,MF] Department of Epigenetic, Oncologic Institute of Principado of Asturias, Oviedo, Spain. [Salguero-Aranda,C; Tejedo,JR; Martin,F; BedoyaFJ] Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER) – University of Pablo de Olavide, Sevilla, Spain | es |
dc.contributor.funder | We were supported by Fundación Progreso y Salud, Consejería de Salud, Junta de Andalucía (Grant PI-0022/2008); Consejería de Innovación Ciencia y Empresa, Junta de Andalucía (Grant CTS-6505; INP-2011-1615-900000); FEDER co-funded grants from Instituto de Salud Carlos III (RD06/0010/0025; PI10/ 00964) and the Ministry of Health and Consumer Affairs (Advanced Therapies Program Grant TRA-120). | |
dc.date.accessioned | 2016-07-05T12:24:53Z | |
dc.date.available | 2016-07-05T12:24:53Z | |
dc.date.issued | 2013-04-04 | |
dc.description | Journal Article; Research Support, Non-U.S. Gov't; | es |
dc.description.abstract | Lineage commitment during embryonic stem cell (ESC) differentiation is controlled not only by a gamut of transcription factors but also by epigenetic events, mainly histone deacetylation and promoter DNA methylation. The DNA demethylation agent 5'-aza-2'-deoxycytidine (AzadC) has been widely described as an effective promoter of cardiomyogenic differentiation in various stem cell types. However, its toxicity and instability complicate its use. Therefore, the purpose of this study was to examine the effects of zebularine (1-(β-D-ribofuranosyl)-1,2-dihydropyrimidin-2-1), a stable and non-toxic DNA cytosine methylation inhibitor, on mouse ESC (mESC) differentiation. Herein, we report that treating embryoid bodies, generated from mESCs, with 30 μM zebularine for 7 days led to greater cell differentiation and induced the expression of several cardiac-specific markers that were detected using reverse transcription-polymerase chain reaction (RT-PCR), real-time PCR, immunostaining and flow cytometry. Zebularine enhanced the expression of cardiac markers and the appearance of beating cells that responded to cardiac drugs, including ion channel blockers (diltiazem) and β-adrenergic stimulators (isoproterenol). Gene promoter methylation status was assessed using methylation-specific PCR (MSP) and validated by bisulfite sequencing analysis. Global gene expression profiling using microarrays showed that zebularine-differentiated cells are distinct from control ESCs. Pathway analysis revealed an enhancement of cellular processes such as embryonic development, cardiovascular system development and function. In addition, the whole-cell proteins exhibited different profiles as analyzed by two-dimensional differential-in-gel-electrophoresis. Our results indicate that zebularine regulates mesodermal differentiation of mESCs, controls promoter methylation of crucial cardiac genes and may help to improve cardiomyogenic differentiation. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Horrillo A, Pezzolla D, Fraga MF, Aguilera Y, Salguero-Aranda C, Tejedo JR, et al. Zebularine regulates early stages of mESC differentiation: effect on cardiac commitment. Cell Death Dis; 4:e570 | es |
dc.identifier.doi | 10.1038/cddis.2013.88 | |
dc.identifier.essn | 2041-4889 | |
dc.identifier.pmc | PMC3668624 | |
dc.identifier.pmid | 23559004 | |
dc.identifier.uri | http://hdl.handle.net/10668/2254 | |
dc.journal.title | Cell Death & Disease | |
dc.language.iso | en | |
dc.publisher | Nature Publishing Group | es |
dc.relation.publisherversion | http://www.nature.com/cddis/journal/v4/n4/full/cddis201388a.html | es |
dc.rights.accessRights | open access | |
dc.subject | Embryonic stem cells | es |
dc.subject | Methylation | es |
dc.subject | Mesoderm | es |
dc.subject | Zebularine | es |
dc.subject | AzadC | es |
dc.subject | Nitric oxide | es |
dc.subject | Células madre embrionaria | es |
dc.subject | Metilación | es |
dc.subject | Mesodermo | es |
dc.subject | Línea celular | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Biological Factors::Biomarkers | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Differentiation | es |
dc.subject.mesh | Medical Subject Headings::Anatomy::Cells::Cells, Cultured::Cell Line | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleosides::Ribonucleosides::Cytidine | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::DNA Methylation | es |
dc.subject.mesh | Medical Subject Headings::Anatomy::Cells::Stem Cells::Embryonic Stem Cells::Embryoid Bodies | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Gene Expression Profiling | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation::Gene Expression Regulation, Developmental | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Metabolic Phenomena::Metabolism::Metabolic Networks and Pathways | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Mice | es |
dc.subject.mesh | Medical Subject Headings::Anatomy::Cells::Muscle Cells::Myocytes, Cardiac | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Nucleic Acid Amplification Techniques::Polymerase Chain Reaction::Real-Time Polymerase Chain Reaction | es |
dc.title | Zebularine regulates early stages of mESC differentiation: effect on cardiac commitment. | es |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 5 of 7
Loading...
- Name:
- Horrillo_Zebularine.pdf
- Size:
- 3.18 MB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo publicado
No Thumbnail Available
- Name:
- Horrillo_Zebularine_Movie1.avi
- Size:
- 111.57 MB
- Format:
- Audio Video Interleave File
- Description:
- Video 1
No Thumbnail Available
- Name:
- Horrillo_Zebularine_Movie2.avi
- Size:
- 79.69 MB
- Format:
- Audio Video Interleave File
- Description:
- Video 2
No Thumbnail Available
- Name:
- Horrillo_Zebularine_Movie3.avi
- Size:
- 95.63 MB
- Format:
- Audio Video Interleave File
- Description:
- Video 3
Loading...
- Name:
- Horrillo_Zebularine_T1.pdf
- Size:
- 110.88 KB
- Format:
- Adobe Portable Document Format
- Description:
- Tabla 1